Praziquantel
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01058 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 46 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | uterine corpus epithelioid leiomyosarcoma | KG + DL |
| 2 | Plasmodium falciparum malaria | KG + DL |
| 3 | retroperitoneal sarcoma | KG + DL |
| 4 | uterine corpus myxoid leiomyosarcoma | KG + DL |
| 5 | anus leiomyosarcoma | KG + DL |
| 6 | small intestinal sarcoma | KG + DL |
| 7 | gnathomiasis | KG + DL |
| 8 | fascioliasis | KG + DL |
| 9 | leiomyosarcoma | KG + DL |
| 10 | dermatofibrosarcoma protuberans | KG + DL |
| 11 | hymenolepiasis | KG + DL |
| 12 | clonorchiasis | KG + DL |
| 13 | fasciolopsiasis | KG + DL |
| 14 | metagonimiasis | KG + DL |
| 15 | paragonimiasis | KG + DL |
| 16 | echinostomiasis | KG + DL |
| 17 | monieziasis | KG + DL |
| 18 | necatoriasis | KG + DL |
| 19 | fascioloidiasis | KG + DL |
| 20 | dicrocoeliasis | KG + DL |
| 21 | acanthocephaliasis | KG + DL |
| 22 | echinococcus granulosus infectious disease | KG + DL |
| 23 | helminthiasis, animal | KG + DL |
| 24 | cystic echinococcosis | KG + DL |
| 25 | angiostrongyliasis | KG + DL |
| 26 | leishmaniasis, diffuse cutaneous | KG + DL |
| 27 | systemic mastocytosis | KG + DL |
| 28 | mastocytoma | KG + DL |
| 29 | Legionnaires’ disease | KG + DL |
| 30 | Smouldering systemic mastocytosis | KG + DL |
| 31 | alveolar echinococcosis | KG + DL |
| 32 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 33 | conventional fibrosarcoma | KG + DL |
| 34 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 35 | kidney fibrosarcoma | KG + DL |
| 36 | isolated genetic hair shaft abnormality | KG + DL |
| 37 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 38 | fibroblastic neoplasm | KG + DL |
| 39 | heart fibrosarcoma | KG + DL |
| 40 | low grade fibromyxoid sarcoma | KG + DL |
| 41 | vestibular neuronitis | KG + DL |
| 42 | brachial plexus neuritis | KG + DL |
| 43 | Cestode infectious disease | KG + DL |
| 44 | acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | KG + DL |
| 45 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 46 | mastocytosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.